🇺🇸 FDA
Patent

US 7815935

Orally distintegrating formulation and process for preparing the same

granted A61KA61K47/183A61K47/36

Quick answer

US patent 7815935 (Orally distintegrating formulation and process for preparing the same) held by Quantum Hi-Tech (Beijing) Research Institute expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Quantum Hi-Tech (Beijing) Research Institute
Grant date
Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K47/183, A61K47/36, A61K9/0056